MedPath

Verification of Imaging System PCD-1000A

Completed
Conditions
Cancer Patients
Interventions
Device: PET/CT imaging
Registration Number
NCT04024748
Lead Sponsor
Canon Medical Systems, USA
Brief Summary

Scope Verification of technologies included in the PCD-1000A PET/CT imaging chain.

* Define and confirm all supported clinical protocols

* Evaluate performance

Detailed Description

The study aim is system verification and associated software. Clinical data and clinical feedback will be used for verification.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Patients already scheduled for an FDG test at SDMI
  • 40 years and older
  • Capable of providing their informed consent
Exclusion Criteria
  • Patients not scheduled for an FDG test at SDMI
  • 39 years or younger
  • Adult female patients that are and/or could become pregnant
  • Not capable of providing their informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients already scheduled for a FDG testPET/CT imagingSubjects will be selected from patients already scheduled for a routine FDG PET/CT test. Only adult patients, 40 years old or older, capable of providing their informed consent, will be selected. Any adult female patients that are pregnant and/or could become pregnant will be excluded. Twenty patients will be recruited.
Primary Outcome Measures
NameTimeMethod
Confirm that PCD-1000A PET/CT System is Effective for Its Intended Use3 months

PCD-1000A PET/CT system's performance will be evaluated for oncology PET imaging on cancer patients to verify that the system performs as expected.

• Verify that all supported clinical protocols from PET acquisition, reconstruction, to presentation (filtering) perform as expected. Images acquired by PCD-1000A PET/CT will be compared with images acquired during a standard-of-care PET/CT scan by a commercially available PET/CT system just prior to imaging with the PCD-1000A PET/CT System. Image quality evaluation will include assessment of uniformity of the liver, delineation of the lungs, presence of artifacts and using Likert scale.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Steinberg Diagnostic Medical Imaging Centers

🇺🇸

Henderson, Nevada, United States

© Copyright 2025. All Rights Reserved by MedPath